Reaearch progress of strategies and mechanisms of targeting bacteria based on nanoparticles

doi:10.3969/j.issn.1674-8115.2022.06.018

Abstract

Abstract:

The crisis of antibiotic resistance is one of the most pressing problems in global public health. To solve the crisis of antibiotic resistance, more and more biological nanomaterials are applied to antimicrobial in recent years. Nanoparticles (NPs) are a class of nanoscale materials with unique advantages compared with traditional antibacterial drugs. However, the application of nanoparticles still faces the dilemma of poor targeting ability and the possible damage to normal tissue. In addition to improving efficacy, targeted therapies allow us to use lower concentrations of highly toxic drugs, thereby reducing the toxic side effects on healthy tissue. Therefore, how to improve the targeting of NPs to bacteria is an important issue today. This article will give an overall introduction to nanoparticles first. Surface modification, stimuli-responsiveness and biomimetic modification of cell membrane, three common bacterial targeting strategies will be introduced later, including their basic mechanisms and the latest findings. The advantages and disadvantages of the three strategies and their future direction will also be summarized. A general picture of the developments in this field will be provided to readers, and it is hoped that new ideas for targeting bacteria will emerge in the future.

Key words: nanoparticle (NP), targeting, surface modification, stimuli-responsive, biomimetics

CLC Number:

R318.08

LUO Zhiyuan, SHI Tingwang, RUAN Zesong, CHEN Yunfeng. Reaearch progress of strategies and mechanisms of targeting bacteria based on nanoparticles[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(6): 819-824.

Figures/Tables 1

TrendMD

References 53

1	NAYLOR N R, ATUN R, ZHU N N, et al. Estimating the burden of antimicrobial resistance: a systematic literature review[J]. Antimicrob Resist Infect Control, 2018, 7: 58.
2	BAPTISTA P V, MCCUSKER M P, CARVALHO A, et al. Nano-strategies to fight multidrug resistant bacteria-“A battle of the titans”[J]. Front Microbiol, 2018, 9: 1441.
3	MILLER K P, WANG L, BENICEWICI B C, et al. Inorganic nanoparticles engineered to attack bacteria[J]. Chem Soc Rev, 2015. 44(21): 7787-7807.
4	PAUL E. Chemotherapeutische trypanosomen-studien[J]. Berliner Klinische Wochenschrift, 1907, 44: 233-236.
5	GUIDO C, MAIORANO G, CORTESE B, et al. Biomimetic nanocarriers for cancer target therapy[J]. Bioengineering (Basel), 2020, 7(3): 111.
6	LI J L, CHEN C Y, XIA T. Understanding nanomaterial-liver interactions to facilitate the development of safer nanoapplications[J]. Adv Mater, 2022, 34(11): e2106456.
7	WANG W, LI P F, XIE R, et al. Designable micro-/ nano-structured smart polymeric materials[J]. Adv Mater, 2021: e2107877. DOI: 10.1002/adma.202107877.
8	NATAN M, BANIN E. From nano to micro: using nanotechnology to combat microorganisms and their multidrug resistance[J]. FEMS Microbiol Rev, 2017, 41(3): 302-322.
9	YIN I X, ZHANG J, ZHAO I S, et al. The antibacterial mechanism of silver nanoparticles and its application in dentistry[J]. Int J Nanomedicine, 2020, 15: 2555-2562.
10	DONG X L, LIANG W X, MEZIANI M J, et al. Carbon dots as potent antimicrobial agents[J]. Theranostics, 2020, 10(2): 671-686.
11	AUGUSTINE R, KALVA N, KIM H N, et al. PH-responsive polypeptide-based smart nano-carriers for theranostic applications[J]. Molecules, 2019, 24: 2961.
12	LANDIS R F, GUPTA A, LEE Y W, et al. Cross-linked polymer-stabilized nanocomposites for the treatment of bacterial biofilms[J]. ACS Nano, 2017, 11(1): 946-952.
13	MAKABENTA J M V, NABAWY A, LI C H, et al. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections[J]. Nat Rev Microbiol, 2021, 19(1): 23-36.
14	ZHANG J L, XIANG Q Q, SHEN L, et al. Surface charge-dependent bioaccumulation dynamics of silver nanoparticles in freshwater algae[J]. Chemosphere, 2020, 247: 125936.
15	LAM S J, O'BRIEN-SIMPSON N M, PANTARAT N, et al. Combating multidrug-resistant gram-negative bacteria with structurally nanoengineered antimicrobial peptide polymers[J]. Nat Microbiol, 2016, 1(11): 16162.
16	HUO S D, JIANG Y, GUPTA A, et al. Fully zwitterionic nanoparticle antimicrobial agents through tuning of core size and ligand structure[J]. ACS Nano, 2016, 10(9): 8732-8737.
17	ELBOURNE A, CHEESEMAN S, ATKIN P, et al. Antibacterial liquid metals: biofilm treatment via magnetic activation[J]. ACS Nano, 2020, 14(1): 802-817.
18	JIN K, LUO Z M, ZHANG B, et al. Biomimetic nanoparticles for inflammation targeting[J]. Acta Pharm Sin B, 2018, 8(1): 23-33.
19	WANG H J, SONG Z Y, LI S J, et al. One stone with two birds: functional gold nanostar for targeted combination therapy of drug-resistant Staphylococcus aureus infection[J]. ACS Appl Mater Interfaces, 2019, 11(36): 32659-32669.
20	KANG S, PARK T, CHEN X Y, et al. Tunable physiologic interactions of adhesion molecules for inflamed cell-selective drug delivery[J]. Biomaterials, 2011, 32(13): 3487-3498.
21	LEHAR S M, PILLOW T, XU M, et al. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus[J]. Nature, 2015, 527(7578): 323-328.
22	GALANZHA E I, SHASHKOV E, SARIMOLLAOGLU M, et al. In vivo magnetic enrichment, photoacoustic diagnosis, and photothermal purging of infected blood using multifunctional gold and magnetic nanoparticles[J]. PLoS One, 2012, 7(9): e45557.
23	CHEN L F, XING S H, LEI Y L, et al. A glucose-powered activatable nanozyme breaking pH and H₂O₂ limitations for treating diabetic infections[J]. Angew Chem Int Ed Engl, 2021, 60(44): 23534-23539.
24	YATVIN M B, WEINSTEIN J N, DENNIS W H, et al. Design of liposomes for enhanced local release of drugs by hyperthermia[J]. Science, 1978, 202(4374): 1290-1293.
25	AMOLI-DIVA M, SADIGHI-BONABI R, POURGHAZI K. Laser-assisted triggered-drug release from silver nanoparticles-grafted dual-responsive polymer[J]. Mater Sci Eng C Mater Biol Appl, 2017, 76: 536-542.
26	MEEKER D G, JENKINS S V, MILLER E K, et al. Synergistic photothermal and antibiotic killing of biofilm-associated Staphylococcus aureus using targeted antibiotic-loaded gold nanoconstructs[J]. ACS Infect Dis, 2016, 2(4): 241-250.
27	BORZENKOV M, MOROS M, TORTIGLIONE C, et al. Fabrication of photothermally active poly(vinyl alcohol) films with gold nanostars for antibacterial applications[J]. Beilstein J Nanotechnol, 2018, 9: 2040-2048.
28	MOHAPATRA A, HARRIS M A, LEVINE D, et al. Magnetic stimulus responsive vancomycin drug delivery system based on chitosan microbeads embedded with magnetic nanoparticles[J]. J Biomed Mater Res B Appl Biomater, 2018, 106(6): 2169-2176.
29	GEILICH B M, GELFAT I, SRIDHAR S, et al. Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication[J]. Biomaterials, 2017, 119: 78-85.
30	HARRIS M, AHMED H, BARR B, et al. Magnetic stimuli-responsive chitosan-based drug delivery biocomposite for multiple triggered release[J]. Int J Biol Macromol, 2017, 104(Pt B): 1407-1414.
31	DAS S S, BHARADWAJ P, BILAL M, et al. Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis[J]. Polymers, 2020, 12(6): 1397.
32	WU J H, LI F Y, HU X, et al. Responsive assembly of silver nanoclusters with a biofilm locally amplified bactericidal effect to enhance treatments against multi-drug-resistant bacterial infections[J]. ACS Cent Sci, 2019, 5(8): 1366-1376.
33	KALHAPURE R S, JADHAV M, RAMBHAROSE S, et al. pH-responsive chitosan nanoparticles from a novel twin-chain anionic amphiphile for controlled and targeted delivery of vancomycin[J]. Colloids Surf B Biointerfaces, 2017, 158: 650-657.
34	WU Y, SONG Z Y, WANG H J, et al. Endogenous stimulus-powered antibiotic release from nanoreactors for a combination therapy of bacterial infections[J]. Nat Commun, 2019, 10(1): 4464.
35	DONG X Y, ZHANG C Y, JIN G, et al. Targeting of nanotherapeutics to infection sites for antimicrobial therapy[J]. Adv Ther (Weinh), 2019, 2(11): 1900095.
36	MA B X, XU H, ZHUANG W H, et al. Reactive oxygen species responsive theranostic nanoplatform for two-photon aggregation-induced emission imaging and therapy of acute and chronic inflammation[J]. ACS Nano, 2020, 14(5): 5862-5873.
37	WANG Z, LIU X Y, DUAN Y W, et al. Infection microenvironment-related antibacterial nanotherapeutic strategies[J]. Biomaterials, 2022, 280: 121249.
38	LI L L, XU J H, QI G B, et al. Core-shell supramolecular gelatin nanoparticles for adaptive and "on-demand" antibiotic delivery[J]. ACS Nano, 2014, 8(5): 4975-4983.
39	CHEN M H, XIE S Z, WEI J J, et al. Antibacterial micelles with vancomycin-mediated targeting and pH/lipase-triggered release of antibiotics[J]. ACS Appl Mater Interfaces, 2018, 10(43): 36814-36823.
40	CANAPARO R, FOGLIETTA F, GIUNTINI F, et al. Recent developments in antibacterial therapy: focus on stimuli-responsive drug-delivery systems and therapeutic nanoparticles[J]. Molecules, 2019, 24(10): 1991.
41	HU C M J, ZHANG L, ARYAL S, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform[J]. Proc Natl Acad Sci USA, 2011, 108(27): 10980-10985.
42	WANG K Y, LEI Y T, XIA D L, et al. Neutrophil membranes coated, antibiotic agent loaded nanoparticles targeting to the lung inflammation[J]. Colloids Surf B Biointerfaces, 2020, 188: 110755.
43	WANG C, WANG Y L, ZHANG L L, et al. Pretreated macrophage-membrane-coated gold nanocages for precise drug delivery for treatment of bacterial infections[J]. Adv Mater, 2018, 30(46): e1804023.
44	WEI X L, RAN D N, CAMPEAU A, et al. Multiantigenic nanotoxoids for antivirulence vaccination against antibiotic-resistant gram-negative bacteria[J]. Nano Lett, 2019, 19(7): 4760-4769.
45	HU Q Y, SUN W J, QIAN C G, et al. Relay drug delivery for amplifying targeting signal and enhancing anticancer efficacy[J]. Adv Mater, 2017, 29(13): 1605803.
46	GAO F, XU L L, YANG B Q, et al. Kill the real with the fake: eliminate intracellular Staphylococcus aureus using nanoparticle coated with its extracellular vesicle membrane as active-targeting drug carrier[J]. ACS Infect Dis, 2019, 5(2): 218-227.
47	DEHAINI D, WEI X L, FANG R H, et al. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization[J]. Adv Mater, 2017, 29(16): 1606209.
48	LI J, ANGSANTIKUL P, LIU W, et al. Biomimetic platelet-camouflaged nanorobots for binding and isolation of biological threats[J]. Adv Mater, 2018, 30(2). DOI:10.1002/adma.201704800.
49	MOLINARO R, CORBO C, MARTINEZ J O, et al. Biomimetic proteolipid vesicles for targeting inflamed tissues[J]. Nat Mater, 2016, 15(9): 1037-1046.
50	BOROVIČKA J, METHERINGHAM W J, MADDEN L A, et al. Photothermal colloid antibodies for shape-selective recognition and killing of microorganisms[J]. J Am Chem Soc, 2013, 135(14): 5282-5285.
51	DALLE VEDOVE E, COSTABILE G, MERKEL O M. Mannose and mannose-6-phosphate receptor-targeted drug delivery systems and their application in cancer therapy[J]. Adv Healthc Mater, 2018, 7(14): e1701398.
52	PI J, SHEN L, YANG E Z, et al. Macrophage-targeted isoniazid-selenium nanoparticles promote antimicrobial immunity and synergize bactericidal destruction of tuberculosis bacilli[J]. Angew Chem Int Ed Engl, 2020, 59(8): 3226-3234.
53	PI J, SHEN L, SHEN H B, et al. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency[J]. Mater Sci Eng C Mater Biol Appl, 2019, 103: 109777.

Category	Advantages	Disadvantages
Surface modification	High targeting efficiency，various forms	Short circulation， safety problems
Stimuli-responsive	Diverse conditions， simpler and more reproducible	Technology limitations to provide stimulus
Biomimetic modification of cell membrane	Prolonged circulation time， cell-specific targeting， detoxification	Technological complexity， lack of raw materials

Category	Advantages	Disadvantages
Surface modification	High targeting efficiency，various forms	Short circulation， safety problems
Stimuli-responsive	Diverse conditions， simpler and more reproducible	Technology limitations to provide stimulus
Biomimetic modification of cell membrane	Prolonged circulation time， cell-specific targeting， detoxification	Technological complexity， lack of raw materials

[1]	YANG Chenkai, LI Wei, CAO Xiangqian, HE Lei, LI Shengzhou, SHEN Bing. Research progress in the treatment of bladder cancer based on nanotechnology [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2023, 43(12): 1562-1568.
[2]	Ting-wang SHI, Yun-feng CHEN. Preparation of cell membrane-coated nanoparticles and its application to antimicrobial [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 953-958.
[3]	Ya-nan LAI, Yu-feng YAO, Xiao-kui GUO, Jin-jing NI. Acetylation involved in bacterial susceptibility to ribosome-targeting antibiotics [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(3): 308-313.
[4]	LIU Xia, YU Wei, YU Dan, CHEN Juan, LUO Xiao-hua, LI Bing. Effects of adenoviral-mediated siRNA targeting PNUTS on proliferation and invasion of laryngeal squamous cell carcinomas Hep-2 cells [J]. , 2018, 38(2): 161-.
[5]	XUE Xiao-mei， CAO Hui-min， YOU Sha-sha， HE Bin. Application of nano drug delivery system to treatment of myocardial ischemia [J]. , 2016, 36(9): 1356-.
[6]	HU Yan, GAO Yan-hong. Research progress of bone-targeting estrogen-like drugs in treatment of osteoporosis [J]. , 2016, 36(3): 437-.
[7]	WANG Yu-qiang, SHENG Jing, CHEN Shu-yan, et al. Detection of transfection efficiency of hepatocyte-targeting Gal-Bu in rat liver cells [J]. , 2013, 33(6): 759-.
[8]	XU Fa-liang, ZHOU Qi, KUANG Yi, et al. Screening of DNA aptamers for recognizing tumor cells by using cell-systematic evolution of ligands by exponential enrichment [J]. , 2013, 33(12): 1684-.